Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
Amicus Therapeutics (Nasdaq: FOLD) said company management will present at two investor conferences in November 2025: the UBS Global Healthcare Conference in Palm Beach Gardens, FL on November 10, 2025 at 2:45 p.m. ET, and the Jefferies Global Healthcare Conference in London on November 18, 2025 at 4:30 p.m. GMT.
Live audio webcasts of both presentations will be available via the company’s investor relations website at https://ir.amicusrx.com/events-and-presentations. Contact details for investor and media relations were provided.
Amicus Therapeutics (Nasdaq: FOLD) ha comunicato che la direzione dell'azienda parteciperà a due conferenze per investitori a novembre 2025: la UBS Global Healthcare Conference a Palm Beach Gardens, FL il 10 novembre 2025 alle ore 14:45 ET, e la Jefferies Global Healthcare Conference a Londra il 18 novembre 2025 alle ore 16:30 GMT.
Le trasmissioni audio in diretta di entrambe le presentazioni saranno disponibili sul sito degli investitori dell'azienda all'indirizzo https://ir.amicusrx.com/events-and-presentations. Sono stati forniti i contatti per le relazioni con gli investitori e i media.
Amicus Therapeutics (Nasdaq: FOLD) anunció que la dirección de la empresa presentará en dos conferencias para inversores en noviembre de 2025: la UBS Global Healthcare Conference en Palm Beach Gardens, FL, el 10 de noviembre de 2025 a las 2:45 p.m. ET, y la Jefferies Global Healthcare Conference en Londres el 18 de noviembre de 2025 a las 4:30 p.m. GMT.
Las transmisiones en vivo por audio de ambas presentaciones estarán disponibles a través del sitio web de relaciones con inversores de la empresa en https://ir.amicusrx.com/events-and-presentations. Se proporcionaron los datos de contacto para relaciones con inversores y medios.
Amicus Therapeutics (Nasdaq: FOLD)는 2025년 11월 두 차례의 투자자 컨퍼런스에서 회사 경영진이 발표할 예정이라고 밝혔다: Palm Beach Gardens, FL에서 열리는 UBS Global Healthcare Conference는 2025년 11월 10일 동부 표준시 14:45, 그리고 런던에서 열리는 Jefferies Global Healthcare Conference는 2025년 11월 18일 GMT 16:30에 개최된다.
두 발표의 라이브 오디오 웹캐스트는 회사의 투자자 관계 웹사이트 https://ir.amicusrx.com/events-and-presentations를 통해 이용 가능하다. 투자자 및 언론 관계 연락처가 제공되었다.
Amicus Therapeutics (Nasdaq: FOLD) a déclaré que la direction de l'entreprise participera à deux conférences investisseurs en novembre 2025 : la UBS Global Healthcare Conference à Palm Beach Gardens, FL, le 10 novembre 2025 à 14h45 ET, et la Jefferies Global Healthcare Conference à Londres, le 18 novembre 2025 à 16h30 GMT.
Les webdiffusions audio en direct des deux présentations seront disponibles sur le site des relations investisseurs de l'entreprise à l'adresse https://ir.amicusrx.com/events-and-presentations. Des coordonnées pour les relations investisseurs et les médias ont été fournies.
Amicus Therapeutics (Nasdaq: FOLD) erklärte, dass das Management des Unternehmens im November 2025 bei zwei Investorenkonferenzen auftreten werde: der UBS Global Healthcare Conference in Palm Beach Gardens, FL am 10. November 2025 um 14:45 Uhr ET und die Jefferies Global Healthcare Conference in London am 18. November 2025 um 16:30 Uhr GMT.
Die Live-Audio-Webcasts beider Präsentationen werden über die Investor-Relations-Website des Unternehmens unter https://ir.amicusrx.com/events-and-presentations verfügbar sein. Kontaktdaten für Investoren- und Medienbeziehungen wurden bereitgestellt.
Amicus Therapeutics (Nasdaq: FOLD) قالت إن إدارة الشركة ستقدم عرضاً في مؤتمرين للمستثمرين في نوفمبر 2025: UBS Global Healthcare Conference في بالم بيتش جاردنز، فلوريدا، في 10 نوفمبر 2025 الساعة 2:45 مساءً بتوقيت شرق الولايات المتحدة، وJefferies Global Healthcare Conference في لندن في 18 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت GMT.
سيكون البث الصوتي المباشر لكلا العرضين متاحاً عبر موقع علاقات المستثمرين بالشركة على https://ir.amicusrx.com/events-and-presentations. وقد تم توفير تفاصيل الاتصال بعلاقات المستثمرين والإعلام.
- None.
- None.
PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.
- 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ET
- Jefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics 
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com 
(609) 662-3809
Media:
Amicus Therapeutics
Brendan McEvoy
Executive Director, External Communications 
bmcevoy@amicusrx.com 
(609) 662-5005
FOLD–G
 
    
      
  
 
             
             
             
             
             
             
             
             
         
         
         
        